 IRVINE, Calif., April 14, 2021 GLOBE NEWSWIRE -- Oncocyte Corporation Nasdaq: OCX, a molecular diagnostics company with a mission to provide actionable answers at critical decision points across the cancer care continuum, today announced that it will host a key opinion leader KOL call on novel biomarkers in identifying appropriate responders to immune checkpoint inhibitors on Monday, April 19, 2021 at 11:30am Eastern Time. 